PTGS1 rs3842792: Understanding Your Genetic Variant
The rs3842792 variant is a single nucleotide polymorphism located within the PTGS1 gene, which encodes the cyclooxygenase-1 (COX-1) enzyme. Research has investigated this variant for its potential role in modulating individual responses to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
What each genotype means
Common genetic variant
This genotype represents the most frequently observed sequence at this location in the PTGS1 gene. While this variant has been studied for potential links to aspirin sensitivity, current evidence is limited and does not provide a definitive clinical prediction for your individual response to medication. Please discuss any concerns regarding aspirin or other NSAID therapy with your clinician or pharmacist.
This is a common genotype found across diverse global populations.
Common genetic variant
You carry one copy of the less common allele at this position in the PTGS1 gene. Research into this variant's role in aspirin intolerance is ongoing, but current data is insufficient to determine if this specific genotype significantly alters your response to treatment. Always consult with your healthcare provider before making changes to your medication regimen.
This heterozygous genotype is observed at varying frequencies in global populations, though it is less common than the homozygous major genotype.
Common genetic variant
This genotype represents the minor allele variant at this position in the PTGS1 gene. While some studies have investigated this variant in the context of cyclooxygenase-1 activity and aspirin sensitivity, the clinical significance remains uncertain and not well-established. You should discuss your medication history and any potential aspirin-related side effects with your doctor or pharmacist.
This genotype is less common than the A/A genotype and is found at varying frequencies across different ancestral groups.
What is the rs3842792 Variant?
The rs3842792 variant is a specific genetic change, or single nucleotide polymorphism (SNP), found within the PTGS1 gene. In human genetics, a SNP represents a variation at a single position in the DNA sequence. This particular variant is situated on chromosome 9. Scientists study such variants to understand how minor differences in our genetic code can lead to variations in how our bodies process medications or respond to environmental factors. Because rs3842792 is located within a gene that plays a critical role in inflammation and platelet function, it has been a subject of interest in pharmacogenomics—the study of how genes affect a person's response to drugs. While the variant is well-documented in genomic databases, its functional impact is complex and remains an area of ongoing scientific inquiry.
The Role of the PTGS1 Gene
The PTGS1 gene provides instructions for making the enzyme cyclooxygenase-1, commonly referred to as COX-1. This enzyme is essential for the production of prostaglandins, which are lipid compounds that act as signaling molecules in the body. Prostaglandins are involved in a wide range of physiological processes, including the regulation of inflammation, the protection of the stomach lining, and the promotion of platelet aggregation, which is necessary for blood clotting. Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) work primarily by inhibiting the activity of COX-1 and its related enzyme, COX-2. By blocking these enzymes, these medications can reduce pain, fever, and inflammation, and prevent blood clots. Because PTGS1 is the primary target for the anti-thrombotic effects of aspirin, variations in this gene are hypothesized to influence how effectively an individual's platelets respond to aspirin therapy.
Research and Evidence Strength
The evidence linking rs3842792 to clinical outcomes is considered moderate. Scientific literature has explored whether genetic variations in PTGS1 contribute to 'aspirin resistance,' a phenomenon where patients do not experience the expected anti-platelet effects of the drug. Some studies have suggested that specific haplotypes—groups of variants inherited together—within the PTGS1 gene may modulate how platelets aggregate in response to aspirin. Furthermore, researchers have investigated whether certain PTGS1 variants are more common in individuals with aspirin-intolerant asthma, a condition characterized by respiratory symptoms following the ingestion of NSAIDs. However, it is important to note that findings in this field can be mixed, and associations observed in one population may not be replicated in others. The complexity of the biological pathways involved means that a single SNP is rarely the sole determinant of a drug response, and environmental or other genetic factors likely play significant roles.
Population Frequency
The rs3842792 variant is classified as a common SNP, meaning it is found at a relatively high frequency across various human populations. Because it is common, many individuals carry one or two copies of the variant allele. Genomic databases indicate that the distribution of this variant can vary by ancestry, which is a standard observation for many common genetic markers. While its prevalence makes it a useful tool for large-scale genetic association studies, the high frequency also suggests that it is not a rare mutation that causes a severe, single-gene disorder. Instead, it is part of the normal spectrum of human genetic diversity. Researchers often use this frequency data to ensure that their studies are representative of diverse groups, helping to clarify whether associations between the variant and drug response are consistent across different ethnic backgrounds.
What You Can Do With This Information
Genetic information regarding variants like rs3842792 is primarily intended for educational and research purposes. It is crucial to understand that this information cannot be used to diagnose a medical condition or to predict with certainty how you will respond to a specific medication. Pharmacogenomic research is still evolving, and clinical decisions regarding medication dosing or the choice of therapy should always be made by a qualified healthcare professional. If you are concerned about your response to aspirin or other NSAIDs, or if you have a history of adverse reactions, you should discuss these concerns with your doctor or pharmacist. They can evaluate your clinical history, current health status, and other medications you may be taking to provide personalized medical advice. Never change your medication regimen based on genetic test results without consulting your clinical care team.
How common is this variant?
The rs3842792 variant is common across global populations, with its specific genotype frequencies varying depending on ancestral background.
Frequently asked questions
Does having the rs3842792 variant mean I am allergic to aspirin?
No, having this variant does not equate to an aspirin allergy. While some research has explored links between PTGS1 variants and aspirin-intolerant asthma, this is a complex condition that involves many factors beyond a single genetic variant.
Can I use this genetic information to change my aspirin dose?
You should never change your medication dosage based on genetic test results. Always consult with your physician or pharmacist before making any changes to your prescribed treatment plan.
Is rs3842792 a rare mutation?
No, rs3842792 is considered a common variant. It is part of the natural genetic variation found in the human population and is not a rare, disease-causing mutation.
Where can I find more information about PTGS1 and drug response?
You can explore resources like PharmGKB or MedlinePlus Genetics for reliable information on pharmacogenomics. These sites provide summaries of how genes can influence drug response based on current scientific evidence.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3842792?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29